
Dr. Anthenelli in the Press:
NEW: Pac-TARC researchers contribute to the development of pharmacological treatment for tobacco use disorder
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES)
Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
NEW: Pac-TARC researchers contribute to the development of pharmacological treatment for tobacco use disorder
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES)
- Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
- Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial
Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial
Relevant News and Media:
Alcohol Use Linked to Lower Connectivity in Brain Areas that Process Emotions
Brain Activity Helps Explain Response to Alcohol and How People Recognize Emotions Before Becoming Intoxicated
COVID-19 Hospitalization '80% More Likely for Smokers'
Drug Deaths Spiked by 30% in 2020
Brain Activity Helps Explain Response to Alcohol and How People Recognize Emotions Before Becoming Intoxicated
COVID-19 Hospitalization '80% More Likely for Smokers'
Drug Deaths Spiked by 30% in 2020